Chongqing Taiji Industry Group Co Ltd
SSE:600129
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Chongqing Taiji Industry Group Co Ltd
SSE:600129
|
CN |
|
Net Insurance SpA
MIL:NET
|
IT |
|
JW Life Science Corp
KRX:234080
|
KR |
|
Noumi Ltd
ASX:NOU
|
AU |
|
K
|
Kent Industrial Co Ltd
TWSE:6606
|
TW |
|
Sangfor Technologies Inc
SZSE:300454
|
CN |
|
Green Cross Holdings
KRX:005250
|
KR |
|
V
|
Vikas Lifecare Ltd
NSE:VIKASLIFE
|
IN |
|
Gps Participacoes e Empreendimentos SA
BOVESPA:GGPS3
|
BR |
|
C
|
Capex SA
BCBA:CAPX
|
AR |
|
I
|
Innuovo Technology Co Ltd
SZSE:000795
|
CN |
|
C
|
Chi Kan Holdings Ltd
HKEX:9913
|
HK |
|
T
|
Tus Pharmaceutical Group Co Ltd
SZSE:000590
|
CN |
|
North Media A/S
CSE:NORTHM
|
DK |
|
Hubei Three Gorges Tourism Group Co Ltd
SZSE:002627
|
CN |
|
B
|
Bangkok Dec-Con PCL
SET:BKD
|
TH |
|
Mapletree Pan Asia Commercial Trust
SGX:N2IU
|
SG |
|
Jasa Armada Indonesia Tbk PT
IDX:IPCM
|
ID |
|
Y
|
YGSOFT Inc
SZSE:002063
|
CN |
|
Allsec Technologies Ltd
BSE:532633
|
IN |
|
A
|
ASX Ltd
OTC:ASXFY
|
AU |
|
Western Forest Products Inc
TSX:WEF
|
CA |
|
Guidewire Software Inc
NYSE:GWRE
|
US |
Relative Value
The Relative Value of one Chongqing Taiji Industry Group Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 16.09 CNY, Chongqing Taiji Industry Group Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Chongqing Taiji Industry Group Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
C
|
Chongqing Taiji Industry Group Co Ltd
SSE:600129
|
8.9B CNY | 0.9 | -25.2 | 142.6 | 142.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP | 4.9 | 28.3 | 15.7 | 22.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.2B CHF | 5.1 | 20.5 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |